Evidence supporting the use of: Barrenwort
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Barrenwort (Epimedium spp.), also known as "Horny Goat Weed," has a long history of traditional use in Chinese medicine for bone health and as a tonic for aging-related conditions, including osteoporosis. The primary bioactive compound in barrenwort is icariin, a flavonoid glycoside. In vitro and animal studies have shown that icariin may promote osteoblast (bone-forming cell) activity and inhibit osteoclast (bone-resorbing cell) activity, potentially reducing bone loss and supporting bone density. Several studies in ovariectomized rats, which are used as models for postmenopausal osteoporosis, have demonstrated that icariin supplementation can improve bone mineral density and bone strength.

However, direct clinical evidence in humans is limited. A few small-scale human studies and clinical trials have suggested potential benefits, such as improved bone turnover markers, but the sample sizes are small and the studies are not of high methodological quality. The evidence is promising but not definitive, and most health authorities do not currently recommend barrenwort as a primary treatment for osteoporosis. Its use is more strongly supported by preclinical research than by large, rigorous human trials. Therefore, while there is a scientific basis for its potential efficacy, the strength of evidence remains low (rated 2/5), and more high-quality clinical trials are needed to confirm its effectiveness and safety for osteoporosis in humans.

More about barrenwort
More about Osteoporosis

Other health conditions supported by barrenwort

Arthritis
Menopause
Osteoporosis
Pain (general remedies for)
Sex Drive (low)